blog.aids.gov — HIV Policy & Programs. Research. New Media.
HIV Policy & Programs. Research. New Media.
The implementation of scientifically proven HIV prevention strategies is helping to reduce the number of new infections — the annual HIV infection rate globally fell by 22 percent from 2001 to 2011 — but a great deal more must be done. Significant scale-up of proven HIV prevention strategies coupled with the discovery of new HIV…
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will stop administering injections in its HVTN 505 clinical trial of an investigational HIV vaccine regimen because an independent data and safety monitoring board (DSMB) found during a scheduled interim review that the vaccine regimen did not prevent HIV infection nor…
This weekend, we observe World Tuberculosis (TB) Day (Sunday, March 24), a day to remember that the global burden of TB remains enormous, particularly among people with HIV/AIDS, among whom TB is the leading cause of death, worldwide. According to the World Health Organization (WHO), in 2011, 1.4 million people died from TB, including 430,000…
On Monday, March 4, 2013, at the Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta, Dr. Deborah Persaud of the Johns Hopkins University presented an intriguing case study of a child who by all measures seems to be cured of HIV infection. This single case has sparked significant conversation, debate, and optimism. This blog…
According to findings of a major HIV prevention trial presented Monday, March 4, 2013 at the 20th Conference on Retroviruses and Opportunistic Infections (CROI), study participants who received daily oral pre-exposure prophylaxis (PrEP) did not experience any protection against HIV compared to those in the placebo arm, likely because very few were taking the study…
Discovery Provides Clues for Potentially Eliminating HIV Infection in Other Children Editor’s note: NIH issued this news release this afternoon about findings announced at the 2013 Conference on Retroviruses and Opportunistic Infections (CROI) which began today in Atlanta, Georgia. The session at which the investigators will be reporting their findings in detail will be webcast…
In an interview with AIDS.gov Director Miguel Gomez, Dr. Carl Dieffenbach discussed how to talk about “a cure” for HIV, and how talk of a cure is different from talk of an “AIDS-free generation.” Dr. Dieffenbach is Director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases (NIAID). According to…
Dr. Howard Koh, Assistant Secretary for Health at HHS, sat down with Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases at NIH to discuss his speech at the opening plenary of AIDS 2012 and his 31 years as a physician and leader in HIV/AIDS scientific research. Having participated in International…
